Investors Target NewLink Execs Over Failed Cancer Vaccine
Investors in NewLink Genetics Corp. on Friday filed a derivative suit in New York federal court, accusing the company's officers and directors of misleading shareholders about the integrity and prospective results...To view the full article, register now.
Already a subscriber? Click here to view full article